Blauvelt, A., Paul, C., van de Kerkhof, P., Warren, R., Gottlieb, A., Langley, R., Brock, F., Arendt, C., Boehnlein, M., Lebwohl, M., & Reich, K. (2020). Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. SKIN The Journal of Cutaneous Medicine, 4(1), S5. Retrieved from https://jofskin.org/33014/index.php/skin/article/view/809